Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_assertion type Assertion NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_head.
- NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_provenance.
- NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_assertion evidence source_evidence_literature NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_provenance.
- NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_assertion SIO_000772 25490527 NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_provenance.
- NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_assertion wasDerivedFrom befree-2016 NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_provenance.
- NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_assertion wasGeneratedBy ECO_0000203 NP1246452.RAtyiyM3t_isQaFyc-w0qIFiLKbcPaCyU80wWpEsrJC7s130_provenance.